Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial H+-transporting ATP synthase, also known as F-type ATPase or F1Fo-ATPase, is a multi-subunit enzyme complex essential for energy production in bacteria [1, 5]. It functions as a rotary motor that couples the flow of protons across the cytoplasmic membrane to the synthesis of ATP from ADP and inorganic phosphate [5, 13]. The enzyme consists of two main sectors: the membrane-embedded Fo sector, which facilitates proton translocation, and the cytoplasmic F1 sector, which catalyzes the chemical reaction [5, 13]. In addition to ATP synthesis, the enzyme can operate in reverse, hydrolyzing ATP to pump protons and maintain pH homeostasis, which is critical for bacterial survival under acidic stress [6, 22]. This target is clinically validated by the drug bedaquiline, a diarylquinoline antibiotic used to treat multidrug-resistant tuberculosis [1, 2]. Bedaquiline selectively inhibits the mycobacterial version of the enzyme by binding to the c-ring and epsilon subunits, stalling the motor and leading to a lethal depletion of cellular ATP [3, 5]. Therapeutic use of bedaquiline is associated with safety concerns such as QTc interval prolongation and hepatotoxicity, necessitating careful patient monitoring [1, 2].
Inhibition of the rotary motor mechanism by binding to the c-subunit and epsilon subunit, preventing proton-coupled ATP synthesis and leading to ATP depletion.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial H+-transporting ATP synthase (F-ATPase).